Core Scientific, Inc. — Form 8-K Summary
Reporting date: June 3, 2024; the report was signed and dated June 4, 2024. The filing reports Regulation FD disclosure regarding expanded hosting agreements with CoreWeave, Inc.
Business Context and Transaction
Core Scientific announced an expansion of its relationship with CoreWeave through a series of agreements to provide additional hosting services. The filing references a related press release and supplementary investor presentation, but their substantive contents are not included in the provided filing text.
- Core Scientific’s common stock trades under the symbol CORZ on Nasdaq.
- The filing also identifies Nasdaq-listed warrants trading under CORZW and CORZZ.
- The company qualifies as an emerging growth company.
Financial and Operating Metrics
The provided Form 8-K text does not disclose revenue, profit, cash flow, margins, debt, liquidity, contract value, hosting capacity, pricing, capital expenditures, or other quantitative financial metrics related to the CoreWeave agreements.
Material Changes Versus Prior Period
The material development is the expansion of the CoreWeave relationship and the execution or contemplation of additional hosting agreements. The filing does not provide comparable-period financial information or quantify the expected change in operating or financial results.
Outlook, Commentary, and Risks
Management indicated that the relationship may affect the company’s financial and operating results, trading multiple, shareholder value, and ability to pursue additional opportunities. The filing states that these expectations are forward-looking and are not guarantees of future performance.
Risks identified include difficulties or unanticipated expenditures; failure to realize expected benefits; operational disruption; management distraction; adverse effects on business, regulatory, or employee relationships; contract termination; delays in required approvals; availability of government incentives; and litigation, judgments, or settlements. Additional risks are referenced in Core Scientific’s other SEC filings.
The disclosure was furnished under Item 7.01 and is not deemed filed for purposes of Section 18 of the Exchange Act, nor incorporated by reference into other filings except through specific reference.
Key Facts for Investors to Verify
- Review Exhibit 99.1 for the detailed terms, duration, economics, and conditions of the CoreWeave hosting agreements.
- Review Exhibit 99.2 for projected hosting capacity, deployment timing, capital requirements, and expected financial contribution.
- Verify whether the agreements are binding, contingent on approvals, or subject to termination rights.
- Assess the concentration and credit risk associated with CoreWeave as a customer or strategic counterparty.
- Compare any projected benefits with subsequent reported revenue, margins, cash flow, debt, and liquidity.
- Note the apparent date inconsistency: the report identifies June 3, 2024 as the earliest reported event, while the listed exhibits are described as dated June 4, 2024.